A recombinant SARS-CoV-2 receptor-binding domain expressed in an engineered fungal strain of Thermothelomyces heterothallica induces a functional immune response in mice-Reference-Cited by-同舟云学术

A recombinant SARS-CoV-2 receptor-binding domain expressed in an engineered fungal strain of Thermothelomyces heterothallica induces a functional immune response in mice

Published:2022-02 Issue:8 Volume:40 Page:1162-1169
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Lazo Laura,Bequet-Romero Monica,Lemos Gilda,Musacchio Alexis,Cabrales Ania,Bruno Andy J.,Ariel Espinosa Luis,Saloheimo Markku,Vitikainen Marika,Hernández Amalia,Emalfarb Mark,Tchelet Ronen,Suzarte Edith,Guillén Gerardo

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference36 articles.

1. Review of Covid-19 vaccine clinical trials - A puzzle with missing pieces;Kwok;Int J Biol Sci,2021

2. SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines;Salvatori;J Transl Med,2020

3. Development of a mature fungal technology and production platform for industrial enzymes based on a Myceliophthora thermophila isolate, previously known as Chrysosporium lucknowense C1;Visser;Ind Biotechnol,2011

4. Development of a Modular Vaccine Platform for Multimeric Antigen Display Using an Orthobunyavirus Model;Aebischer;Vaccines (Basel),2021

5. 'Schmallenberg virus'–a novel orthobunyavirus emerging in Europe;Beer;Epidemiol Infect,2013

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Nasal Vaccine Candidate, Containing Three Antigenic Regions from SARS-CoV-2, to Induce a Broader Response;Vaccines;2024-05-28

2. Current Progress, Challenges and Prospects in the Development of COVID-19 Vaccines;Drugs;2024-04

3. Filamentous fungus-produced human monoclonal antibody provides protection against SARS-CoV-2 in hamster and non-human primate models;Nature Communications;2024-03-14

4. The Nucleocapsid Protein of SARS-CoV-2, Combined with ODN-39M, Is a Potential Component for an Intranasal Bivalent Vaccine with Broader Functionality;Viruses;2024-03-08

5. Production and characterization of a chimeric antigen, based on nucleocapsid of SARS-CoV-2 fused to the extracellular domain of human CD154 in HEK-293 cells as a vaccine candidate against COVID-19;PLOS ONE;2023-09-26